AI assistant
H. Lundbeck A — Director's Dealing 2012
May 24, 2012
3367_rpt_2012-05-24_0bd609d7-6439-447b-ac7e-2558bf66ce4e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
H. Lundbeck A/S
DK-2500 Valby, Copenhagen Fax +45 36 43 82 62 www.lundbeck.com CVR number: 56759913
Ottiliavej 9 Tel +45 36 30 13 11 E-mail [email protected]
Corporate Release No 470
24 May 2012
Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities
H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act.
The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday.
| Name: | Anders Götzsche |
|---|---|
| Job position of the executive: | Executive Vice President & CFO |
| ID code (ISIN code): | DK 0010287234 |
| Description of the security: | Share |
| Nature of the transaction: | Transferred as part of Lundbeck's Long Term |
| Incentive Program for Executive Management | |
| Date of trading: | 23 May 2012 |
| Market on which the trading was effected: | Nasdaq OMX Copenhagen |
| Number of traded securities: | 30,823 shares |
Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H. Lundbeck A/S and persons/entities closely associated to them.
Closely associated persons/entities means inter alia:
- spouse or cohabitant
- children below the age of 18
- legal entities in which the insider has a controlling influence
The content of this release will have no influence on the Lundbeck Group's financial expectations for 2012.
Lundbeck contacts
Investors: Media:
Palle Holm Olesen Mads Kronborg Chief Specialist, Head of Investor Relations Media Relations Manager [email protected] [email protected] +45 36 43 24 26 +45 36 43 28 51
Magnus Thorstholm Jensen Simon Mehl Augustesen [email protected] [email protected] +45 36 43 38 16 +45 36 43 49 80
Investor Relations Officer International Media Specialist
About Lundbeck
H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.
Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with brain disorders. In 2011, the company's revenue was DKK 16.0 billion (approximately EUR 2.1 billion or USD 3.0 billion). For more information, please visit www.lundbeck.com.